AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
TransMedics Group, Inc. Common Stock
XNAS · usd
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG00NZ6J701
70.74▼ 1.32 (-1.83%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
72.06
Day's Range
69.76 – 72.68
52-Week Range
60.11 – 156.00
Volume
789.6K
Avg Volume
788.9K
Share Statistics
Shares Outstanding
Employees
898
Exchange
XNAS
Listed
2019-05-02
Share count as of July 30, 2026

TransMedics Group, Inc. Common Stock (TMDX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about TransMedics Group, Inc. Common Stock (TMDX)
What is TransMedics Group, Inc. Common Stock's Market Cap?
TransMedics Group, Inc. Common Stock's Market Cap is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's Enterprise Value?
TransMedics Group, Inc. Common Stock's Enterprise Value is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's Trailing P/E?
TransMedics Group, Inc. Common Stock's Trailing P/E is 16.2×, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's Price / Sales?
TransMedics Group, Inc. Common Stock's Price / Sales is 3.7×, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's EV / Revenue?
TransMedics Group, Inc. Common Stock's EV / Revenue is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's EV / EBITDA?
TransMedics Group, Inc. Common Stock's EV / EBITDA is 20.1×, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's Revenue (TTM)?
TransMedics Group, Inc. Common Stock's Revenue (TTM) is $668.5M, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's Net Income (TTM)?
TransMedics Group, Inc. Common Stock's Net Income (TTM) is $151.7M, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's EBITDA?
TransMedics Group, Inc. Common Stock's EBITDA is $118.0M, based on as-reported figures from SEC (XBRL) filings.
What is TransMedics Group, Inc. Common Stock's Diluted EPS (TTM)?
TransMedics Group, Inc. Common Stock's Diluted EPS (TTM) is 4.37, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TMDXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth+20.7%+21.2%+32.2%+32.2%
Cost of revenue:
Total cost of revenue
Gross profit
% of revenue59.6%58.2%58.1%58.8%
Operating expenses:
Research, development and clinical trials
Acquired in-process research and development expenses————
Selling, general and administrative
Total operating expenses
% of revenue47.1%50.5%44.9%42.6%
Income from operations
% of revenue12.5%7.6%13.2%16.2%
Other income (expense):
Interest expense
Interest income and other income (expense), net
Total other expense, net
Income before income taxes
Provision for income taxes
Net income
% of revenue7.7%4.2%65.6%16.9%
Net income per share, basic
Net income per share, diluted